SOAP Note: 35-Year-Old Female with Worsening Anxiety, Fatigue, Diabetes, and Irregular Menstrual Cycles
SUBJECTIVE
Chief Complaint: Follow-up for worsening anxiety, increased fatigue, diabetes management, and irregular menstrual cycles.
History of Present Illness:
- Anxiety: Quantify severity using validated screening (e.g., GAD-7 score), duration of worsening symptoms, specific triggers, interference with daily activities and diabetes self-management, presence of panic attacks, social avoidance, or excessive worry. Screen for comorbid depression (PHQ-9) as 50-60% of patients with anxiety have comorbid mood disorders 1.
- Fatigue: Onset, severity (0-10 scale), impact on function, relationship to blood glucose patterns, sleep quality and duration (screen for obstructive sleep apnea), mood disturbances, and timing relative to menstrual cycle.
- Diabetes: Type (1 or 2), duration, current medications and adherence, frequency of blood glucose monitoring, recent glucose patterns (obtain CGM data if available), hypoglycemic episodes (frequency, awareness, timing), last HbA1c, presence of complications.
- Menstrual History: Cycle length and regularity pattern, age at menarche, last menstrual period, relationship between glucose control and cycle phases (women with diabetes experience glycemic variability across menstrual phases with worsening in late luteal phase) 2, 3, associated symptoms (dysmenorrhea, mood changes).
Past Medical History: Duration of diabetes, thyroid disease, cardiovascular disease, psychiatric history, autoimmune conditions.
Medications: Current diabetes regimen (insulin doses/oral agents), any psychotropic medications, hormonal contraception, supplements.
Social History: Stress levels (work, relationships, financial), alcohol use, tobacco, substance use, exercise patterns, eating behaviors, support system, food security, housing stability 4.
Review of Systems: Weight changes, heat/cold intolerance, palpitations, chest pain, shortness of breath, cognitive difficulties, numbness/tingling, vision changes, polyuria/polydipsia, galactorrhea, hirsutism.
OBJECTIVE
Vital Signs: Height, weight, BMI, blood pressure (seated and orthostatic if indicated), heart rate.
Physical Examination:
- General: Appearance, affect, level of distress
- Thyroid: Palpation for enlargement or nodules (thyroid dysfunction is a reversible cause of both fatigue and anxiety) 5
- Cardiovascular: Heart sounds, peripheral pulses (screen for peripheral arterial disease given irregular cycles increase cardiovascular risk) 6, 7
- Skin: Acanthosis nigricans, hirsutism, acne, insulin injection sites for lipodystrophy 4
- Neurologic: Mood, affect, cognitive function
- Extremities: Comprehensive foot exam including monofilament testing, pedal pulses 4
Laboratory Data (if not recent):
- Diabetes monitoring: HbA1c, fasting glucose, lipid panel
- Thyroid function: TSH, free T4 (essential given fatigue and anxiety symptoms) 8
- Reproductive hormones: FSH, LH, estradiol, prolactin, total testosterone, DHEA-S (if clinical hyperandrogenism present), AMH 8
- Other: CBC (anemia causes fatigue), comprehensive metabolic panel, vitamin D
- Consider: 8 AM cortisol if Cushing's suspected, inflammatory markers if chronic illness suspected
ASSESSMENT
35-year-old female with multiple interconnected conditions requiring integrated management:
Worsening Anxiety Disorder - Likely generalized anxiety disorder given presentation; screen formally with validated tool and assess for interference with diabetes self-management and quality of life 9, 10. Women with diabetes have 19.5% lifetime prevalence of generalized anxiety disorder 10. Anxiety symptoms may fluctuate with menstrual cycle phases 11.
Fatigue - Differential includes:
- Thyroid dysfunction (hypothyroidism most common)
- Poor glycemic control or hypoglycemia
- Anemia
- Depression (comorbid with anxiety in 50-60% of cases) 1
- Sleep disturbance/obstructive sleep apnea
- Cardiac dysfunction
- Hormonal fluctuations related to menstrual irregularity
Diabetes Mellitus - Assess current control and complications. Note that menstrual irregularity increases risk of worsening diabetes control and cardiovascular disease by 17-75% 6, 7. Glycemic variability occurs across menstrual phases with decreased time-in-range during luteal phase 2, 3.
Irregular Menstrual Cycles - This is a critical risk marker: irregular cycles confer 20% increased risk of heart disease, 17% increased risk of diabetes progression, 50% increased risk of hypertension, and 62% increased risk of cerebrovascular disease 6, 7. Differential includes:
- Polycystic ovary syndrome (PCOS) - most common
- Hypothalamic amenorrhea (stress, weight, exercise-related)
- Thyroid dysfunction
- Hyperprolactinemia
- Primary ovarian insufficiency
- Hypothalamic-pituitary dysfunction
PLAN
Immediate Priorities:
1. Anxiety Management 1, 9, 10
Assess severity and implement stepped-care approach:
- Mild symptoms: Psychoeducation, lifestyle modifications (regular physical activity, stress management), cognitive behavioral therapy referral
- Moderate-to-severe symptoms OR interference with diabetes self-management:
- Offer pharmacotherapy with SSRI/SNRI as first-line (e.g., sertraline 50mg daily, titrate to 100-200mg; or escitalopram 10mg daily, titrate to 20mg)
- Refer to mental health professional for evidence-based psychotherapy (CBT, mindfulness-based interventions)
- Provide education about anxiety and diabetes interaction - anxiety worsens glycemic control and increases diabetes distress
- Reassess biweekly until symptom improvement, then monthly 1
2. Fatigue Workup 5
Order laboratory evaluation TODAY:
- TSH, free T4 (thyroid dysfunction is reversible cause)
- CBC with differential (anemia)
- Comprehensive metabolic panel (renal function, electrolytes)
- Review recent HbA1c and glucose patterns
Based on results:
- If hypothyroid: Initiate levothyroxine replacement
- If anemic: Determine etiology and treat
- If related to mood disorder: Treat anxiety/depression as above
- If sleep-related: Screen for obstructive sleep apnea with validated questionnaire; refer for sleep study if positive
- Counsel on regular physical activity - improves both fatigue and anxiety 5
3. Diabetes Optimization 10, 4
- Review glucose monitoring data - assess for patterns related to menstrual cycle phases (expect worsening in late luteal phase with 6% decrease in time-in-range) 2, 3
- Screen for diabetes distress using validated tool
- Adjust insulin/medications accounting for menstrual cycle variability:
- Insulin requirements increase ~10% during luteal phase 3
- Consider temporary basal rate increases or correction factor adjustments days 14-28 of cycle
- Assess for hypoglycemia awareness - if impaired, refer for blood glucose awareness training 10
- Target HbA1c <7% while minimizing hypoglycemia
- Screen for complications: Ensure annual dilated eye exam, urine albumin-to-creatinine ratio, comprehensive foot exam completed 4
4. Menstrual Irregularity Evaluation 8, 6, 7
Order hormone panel TODAY:
- FSH, LH, estradiol, prolactin (morning draw)
- Total testosterone, DHEA-S
- TSH, free T4 (if not already ordered above)
- Consider: AMH, 8 AM 17-hydroxyprogesterone if clinical hyperandrogenism
Interpretation algorithm:
- High FSH/LH with low estradiol (<20 pg/mL): Primary ovarian insufficiency - refer to reproductive endocrinology
- Low/normal FSH/LH with low estradiol: Hypothalamic amenorrhea or PCOS - assess for eating disorder, excessive exercise, stress
- Elevated testosterone/DHEA-S: PCOS likely - manage metabolic syndrome components
- Elevated prolactin (>100 ng/mL): MRI pituitary, refer to endocrinology
- Abnormal TSH: Treat thyroid dysfunction
5. Cardiovascular Risk Mitigation 6, 7
Given irregular cycles, this patient has significantly elevated cardiovascular risk:
- Check lipid panel - irregular cycles increase hypercholesterolemia risk by 33% 6
- Monitor blood pressure - irregular cycles increase hypertension risk by 50% 6
- Optimize diabetes control - irregular cycles increase diabetes complications
- Counsel on lifestyle: Mediterranean diet, 150 minutes/week moderate exercise, smoking cessation if applicable
- Consider low-dose aspirin if 10-year ASCVD risk >10%
Follow-Up Schedule:
- 2 weeks: Review laboratory results, adjust medications, reassess anxiety symptoms
- 4-6 weeks: Evaluate response to anxiety treatment; if poor compliance or inadequate response after 8 weeks, modify treatment plan 1
- 3 months: Repeat HbA1c, reassess all symptoms, evaluate menstrual pattern changes
- Ongoing: Biweekly to monthly follow-up until anxiety symptoms remit 1
Referrals:
- Mental health professional - for evidence-based psychotherapy (CBT) for anxiety 1, 10
- Endocrinology - if hormone workup reveals primary ovarian insufficiency, pituitary pathology, or complex diabetes management needs
- Reproductive endocrinology - if fertility concerns or PCOS management needed
- Diabetes educator - for menstrual cycle-related insulin adjustment education 2, 3
Patient Education:
- Anxiety-diabetes connection: Explain bidirectional relationship and importance of treating both
- Menstrual cycle effects on glucose: Educate about expected glycemic variability (worsening luteal phase) and proactive insulin adjustments 2, 3
- Cardiovascular risk: Emphasize that irregular cycles are an early warning sign requiring aggressive risk factor management 6, 7
- Hypoglycemia prevention: Always carry fast-acting carbohydrates, wear medical alert identification
- When to call: Severe hypoglycemia, worsening anxiety interfering with function, suicidal ideation, chest pain, new neurologic symptoms
Critical Pitfalls to Avoid:
- Do not dismiss menstrual irregularity as benign - it is a powerful predictor of cardiovascular and metabolic disease 6, 7
- Do not treat anxiety without screening for depression - 50-60% have comorbid conditions 1
- Do not overlook thyroid dysfunction - it causes fatigue, anxiety, menstrual irregularity, and worsens diabetes control 8
- Do not ignore diabetes distress - distinct from depression and requires specific assessment 10
- Do not fail to educate about menstrual cycle-glucose patterns - empowers proactive management 2, 3